Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-010311
Filing Date
2015-02-06
Accepted
2015-02-06 16:06:47
Documents
1
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 2745
  Complete submission text file 0001209191-15-010311.txt   4128
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Issuer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VICURON PHARMACEUTICALS INC 455 S GULPH ROAD SUITE 305 KING OF PRUSSIA PA 19406
Business Address
DUNTON ALAN W (Reporting) CIK: 0001304773 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-32188 | Film No.: 15584553